Antibiotic trial targets toxic brain fog in liver patients
NCT ID NCT05754996
Summary
This study tested whether an antibiotic called nifuroxazide could safely treat brain fog (hepatic encephalopathy) in people with advanced liver disease. It involved 80 Egyptian patients hospitalized with moderate to severe symptoms. The goal was to see if the drug could clear the brain fog by reducing gut bacteria that produce harmful toxins absorbed by the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC ENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Hepatology and Tropical Medicine Research Institute (NHTMRI)
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.